ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

EWTX Edgewise Therapeutics Inc

19.52
0.23 (1.19%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Edgewise Therapeutics Inc EWTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.23 1.19% 19.52 13:00:10
始値 安値 高値 終値 前日終値
19.74 19.44 20.12 19.52 19.29
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2321:00BWEdgewise Receives European Medicines Agency (EMA) Orphan..
2024/4/1605:05BWEdgewise Therapeutics Announces Positive Two-Year Topline..
2024/3/2821:00BWEdgewise Therapeutics Announces Upcoming Podium Presentation..
2024/3/2721:00BWEdgewise Therapeutics to Present at the Cantor Virtual..
2024/3/0522:00BWEdgewise Therapeutics to Present at the Leerink Partners..
2024/2/2822:00BWEdgewise Therapeutics to Present on EDG-5506 for the..
2024/2/2222:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2222:00EDGAR2Form 8-K - Current report
2024/2/2222:00BWEdgewise Therapeutics Reports Fourth Quarter and Full Year..
2024/2/1422:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1322:00BWEdgewise Receives U.S. FDA Fast Track Designation for..
2024/2/1007:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0806:15EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2006:54EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1922:44EDGAR2Form 8-K - Current report
2024/1/1922:37BWEdgewise Therapeutics Announces Pricing of $240 Million..
2024/1/1920:05EDGAR2Form 8-K - Current report
2024/1/1920:04EDGAR2Form S-3MEF - Registration adding securities to prior Form..
2024/1/1920:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/0922:39BWEdgewise Therapeutics Highlights 2023 Accomplishments and..
2023/12/2906:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2706:32EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1922:00BWEdgewise Therapeutics to Present at the 42nd Annual J.P...
2023/12/1822:00BWEdgewise Therapeutics Launches First of Its Kind Educational..
2023/11/3022:56DJNEdgewise Gets FDA Orphan, Rare-Pediatric-Disease..
2023/11/3022:00BWEdgewise Receives Orphan Drug and Rare Pediatric Disease..
2023/11/0922:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:00EDGAR2Form 8-K - Current report
2023/11/0922:00BWEdgewise Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0822:00BWEdgewise Therapeutics to Present at Upcoming Investor..
2023/11/0121:00BWEdgewise to Present Data on EDG-7500 at the American Heart..
2023/10/2621:00BWEdgewise Therapeutics Announces Expansion of their EDG-5506..
2023/9/2721:00BWEdgewise Therapeutics to Present on EDG-5506 for Becker..
2023/9/2621:00BWEdgewise Therapeutics Announces Initiation of GRAND CANYON,..
2023/9/1421:00BWEdgewise Therapeutics Begins Dosing First-in-Human Phase 1..
2023/8/1908:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1908:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1021:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1021:00EDGAR2Form 8-K - Current report
2023/8/1021:00BWEdgewise Therapeutics Reports Second Quarter 2023 Financial..
2023/7/1505:05EDGAR2Form 8-K - Current report
2023/6/2705:01BWEdgewise Therapeutics Announces Positive 12-Month Topline..
2023/6/0621:00BWEdgewise Therapeutics to Present at the Goldman Sachs Global..
2023/5/1121:00BWEdgewise Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock